Open main menu
Search Ctrl + K
Free Trial
Loading...
Talaris Therapeutics, Inc.
Watch
Biological Products, (no Diagnostic Substances)
NASDAQ.TALS
570 Preston St., Suite 400, Louisville, KY, 40202
Categorized
Chronological
Ownership by Owner
Insider Transactions
Institutional Owners
Filings by Form Type
Transcripts
Your Highlights
Search Within Documents
Key Exhibits
Articles & Bylaws
Indentures
Material contracts
Plans of Reorganization
Underwriting Agreements
External Links
Google Finance
SEC EDGAR
Loading...
Loading...
Loading...
Loading...
Loading...
Loading...
News
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
07 Nov 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
10 Oct 24
8-K
Amendments To Articles Of Incorporation Or Bylaws; Change In Fiscal Year
11 Sep 24
8-K
Regulation Fd Disclosure, Financial Statements And Exhibits
05 Sep 24
8-K
Results Of Operations And Financial Condition, Financial Statements And Exhibits
08 Aug 24
8-K
Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers: Compensatory Arrangements Of Certain Officers
27 Jun 24
8-K
Other Events, Financial Statements And Exhibits
14 Nov 23
Proxies
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
19 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
19 Apr 24
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
28 Apr 23
DEFA14A
Additional Definitive Proxy Soliciting Materials And Rule 14(a)(12) Material.
29 Apr 22
DEF 14A
Definitive Proxy Statement Provided In Advance Of A Shareholder Meeting.
29 Apr 22
Financials
10-Q
Quarterly Filing
07 Nov 24
10-Q
Quarterly Filing
08 Aug 24
10-Q
Quarterly Filing
13 May 24
10-K
Fiscal Year 2023
19 Mar 24
10-Q
Quarterly Filing
14 Nov 23
10-Q
Quarterly Filing
14 Aug 23
10-Q
Quarterly Filing
15 May 23
Other
EFFECT
Notice Of Effectiveness For A Previously Filed Sec Document.
14 Nov 24
S-3
Registration Statement Under The Securities Act.
07 Nov 24
ARS
Scanned Paper Annual Report Submission.
19 Apr 24
425
Filed In Connection With Business Combination Subject To Rule 425.
10 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
10 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
06 Oct 23
425
Filed In Connection With Business Combination Subject To Rule 425.
26 Sep 23
Ownership
SC 13G/A
14 Nov 24
SC 13G/A
14 Nov 24
SC 13G
14 Nov 24
SC 13G/A
14 Nov 24
SC 13G/A
14 Nov 24
SC 13G
08 Nov 24
SC 13G
22 Oct 24
Prospectuses and Registrations
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
19 Mar 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
26 Jan 24
424B5
Prospectus Filed Pursuant To Rule 424(b)(5).
25 Jan 24
S-8
Registration Of Securities To Be Offered To Employees In Employee Benefit Plans.
23 Oct 23
424B3
Prospectus Filed Pursuant To Rule 424(b)(3).
15 Sep 23
S-4/A
Amendment To The S-4 Registration Statement.
13 Sep 23
S-4/A
Amendment To The S-4 Registration Statement.
11 Sep 23